Chronic Hyperphosphatemia and Vascular Calcification Are Reduced by Stable Delivery of Soluble Klotho-Reference-Cited by-同舟云学术

Chronic Hyperphosphatemia and Vascular Calcification Are Reduced by Stable Delivery of Soluble Klotho

Published:2016-11-11 Issue:4 Volume:28 Page:1162-1174
ISSN:1046-6673
Container-title:Journal of the American Society of Nephrology
language:en
Short-container-title:JASN

Author:

Hum Julia M.,O’Bryan Linda M.,Tatiparthi Arun K.,Cass Taryn A.,Clinkenbeard Erica L.,Cramer Martin S.,Bhaskaran Manoj,Johnson Robert L.,Wilson Jonathan M.,Smith Rosamund C.,White Kenneth E.

Publisher

American Society of Nephrology (ASN)

Subject

Nephrology,General Medicine

Reference66 articles.

1. Fibroblast Growth Factor 23 (FGF23) Predicts Progression of Chronic Kidney Disease: The Mild to Moderate Kidney Disease (MMKD) Study

2. Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population

3. Fibroblast Growth Factor 23 and Mortality among Patients Undergoing Hemodialysis

4. Fibroblast Growth Factor-23 and Cardiovascular Events in CKD

5. Fibroblast Growth Factor-23 and Death, Heart Failure, and Cardiovascular Events in Community-Living Individuals

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lessons from Klotho mouse models to understand mineral homeostasis;Acta Physiologica;2024-08-23

2. Soluble Klotho, a Potential Biomarker of Chronic Kidney Disease–Mineral Bone Disorders Involved in Healthy Ageing: Lights and Shadows;International Journal of Molecular Sciences;2024-02-03

3. Research Progress on Vascular Calcification in Maintenance Hemodialysis Patients;Advances in Clinical Medicine;2024

4. Emerging role of α-Klotho in energy metabolism and cardiometabolic diseases;Diabetes & Metabolic Syndrome: Clinical Research & Reviews;2023-10

5. FGF23 and klotho at the intersection of kidney and cardiovascular disease;Nature Reviews Cardiology;2023-07-13